Cameron John Reynolds - Dec 8, 2021 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: President and CEO, Director
Signature: /s/ Cameron John Reynolds
Stock symbol: VNRX
Transactions as of: Dec 8, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/10/2021, 03:05 PM
Previous filing: Nov 5, 2021
Next filing: Apr 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Stock Option (Right to Buy)	Disposed to Issuer		-85K	-100%		0	Dec 8, 2021	Common Stock	85K	$3.60	Direct	F1
transaction	VNRX	Stock Option (Right to Buy)	Award		+85K			85K	Dec 8, 2021	Common Stock	85K	$3.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant).

Content

The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant).